Related Experiment Videos
Microbiota-liver axis in hepatic disease.
Benoit Chassaing1, Lucie Etienne-Mesmin, Andrew T Gewirtz
1Center for Inflammation, Immunity, and Infection and Department of Biology, Georgia State University, Atlanta, GA.
Hepatology (Baltimore, Md.)
|May 25, 2013
Summary
The gut microbiota influences liver inflammation by activating the innate immune system. Manipulating gut bacteria may offer new treatments for chronic liver diseases.
Area of Science:
- Microbiology
- Hepatology
- Immunology
Background:
- The gut microbiota is a known factor in intestinal inflammation.
- Emerging evidence links gut microbiota to chronic inflammatory liver diseases.
- A central hypothesis suggests microbial products trigger innate immunity, promoting liver inflammation.
Purpose of the Study:
- To review the evidence supporting the gut microbiota's role in chronic liver disease.
- To explain how this hypothesis applies to known and new liver disease epidemiology.
- To discuss potential microbiota-targeted therapies for liver disease.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of epidemiological data in relation to microbiota.
- Discussion of therapeutic strategies targeting the gut microbiome.
Main Results:
- The gut microbiota's role in liver inflammation is supported by accumulating evidence.
- Microbial products activating innate immunity provide a plausible mechanism for liver disease.
- The hypothesis can explain various forms of chronic inflammatory liver disease.
Conclusions:
- The gut microbiota is a significant factor in chronic inflammatory liver disease.
- Targeting the gut microbiota holds promise for preventing and treating liver conditions.
- Further research into microbiota-host interactions is crucial for therapeutic development.
Related Concept Videos
01:22Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...